|
Wednesday 1st July 2020 |
Text too small? |
AFT Pharmaceuticals Limited (NZX: AFT /ASX:AFP) (AFT) announced today that its NZ$2 million share purchase plan (SPP) has closed oversubscribed. The SPP received strong shareholder support with AFT receiving applications totalling approximately NZ$9.8 million. Applications will be scaled on a proportionate basis in accordance with the number of AFT shares held by applicants on the SPP record date (9 June 2020). Refunds of surplus application amounts paid will be made to applicants in accordance with the terms of the SPP offer document. See link below for detail.
No comments yet
BRM - Barramundi Limited Investment Mandate
Devon Funds Morning Note - 30 October 2026
VGL - Vista Group appoints Rob Hamilton as Independent Director
PCT - announces Downtown decision, capital return & buyback
FSF - Fonterra lifts forecast 2026/27 Farmgate Milk Price
October 30th Morning Report
BPG - Blackpearl signs US data partnership agreement
POT Annual Meeting 2026: Chair and Chief Executive's Speech
MEE - First half FY27 outlook / Series 1 Warrant exercise update
ERD - HY27 Results Announcement Date